Annual total expenses:
$1.77B+$280.00M(+18.76%)Summary
- As of today (May 29, 2025), NBIX annual total expenses is $1.77 billion, with the most recent change of +$280.00 million (+18.76%) on December 31, 2024.
- During the last 3 years, NBIX annual total expenses has risen by +$846.60 million (+91.46%).
- NBIX annual total expenses is now at all-time high.
Performance
NBIX Total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly total expenses:
$548.90M+$66.20M(+13.71%)Summary
- As of today (May 29, 2025), NBIX quarterly total expenses is $548.90 million, with the most recent change of +$66.20 million (+13.71%) on March 31, 2025.
- Over the past year, NBIX quarterly total expenses has increased by +$138.90 million (+33.88%).
- NBIX quarterly total expenses is now at all-time high.
Performance
NBIX Quarterly total expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total expenses Formula
Total Expenses = Cost of Goods Sold + Operating Expenses + Non Operating Expenses
NBIX Total expenses Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +18.8% | +33.9% |
3 y3 years | +91.5% | +78.5% |
5 y5 years | +215.6% | +208.0% |
NBIX Total expenses Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +91.5% | at high | +82.9% |
5 y | 5-year | at high | +215.6% | at high | +211.7% |
alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
NBIX Total expenses History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $548.90M(+13.7%) |
Dec 2024 | $1.77B(+18.8%) | $482.70M(+10.4%) |
Sep 2024 | - | $437.30M(-1.1%) |
Jun 2024 | - | $442.30M(+7.9%) |
Mar 2024 | - | $410.00M(+12.4%) |
Dec 2023 | $1.49B(+20.4%) | $364.90M(+2.0%) |
Sep 2023 | - | $357.60M(-5.7%) |
Jun 2023 | - | $379.10M(-3.0%) |
Mar 2023 | - | $390.70M(+26.6%) |
Dec 2022 | $1.24B(+33.9%) | $308.60M(+2.8%) |
Sep 2022 | - | $300.10M(-7.2%) |
Jun 2022 | - | $323.50M(+5.2%) |
Mar 2022 | - | $307.50M(+24.0%) |
Dec 2021 | $925.70M(+28.9%) | $248.00M(-1.4%) |
Sep 2021 | - | $251.50M(+13.7%) |
Jun 2021 | - | $221.10M(+7.8%) |
Mar 2021 | - | $205.10M(+16.5%) |
Dec 2020 | $718.40M(+27.9%) | $176.10M(-4.4%) |
Sep 2020 | - | $184.30M(+2.5%) |
Jun 2020 | - | $179.80M(+0.9%) |
Mar 2020 | - | $178.20M(+12.0%) |
Dec 2019 | $561.50M(+37.1%) | $159.10M(+20.5%) |
Sep 2019 | - | $132.00M(-8.4%) |
Jun 2019 | - | $144.10M(+14.1%) |
Mar 2019 | - | $126.30M(+20.4%) |
Dec 2018 | $409.60M(+55.7%) | $104.88M(+7.6%) |
Sep 2018 | - | $97.43M(-1.3%) |
Jun 2018 | - | $98.76M(-9.0%) |
Mar 2018 | - | $108.53M(+106.0%) |
Dec 2017 | $262.99M(+62.0%) | $52.68M(-21.1%) |
Sep 2017 | - | $66.77M(+5.0%) |
Jun 2017 | - | $63.60M(-20.4%) |
Mar 2017 | - | $79.93M(+72.8%) |
Dec 2016 | $162.37M(+42.5%) | $46.25M(+20.3%) |
Sep 2016 | - | $38.44M(-8.1%) |
Jun 2016 | - | $41.83M(+16.7%) |
Mar 2016 | - | $35.86M(+16.6%) |
Dec 2015 | $113.97M(+76.9%) | $30.75M(-14.2%) |
Sep 2015 | - | $35.84M(+41.6%) |
Jun 2015 | - | $25.32M(+14.8%) |
Mar 2015 | - | $22.06M(+7.8%) |
Dec 2014 | $64.41M(+22.5%) | $20.47M(+21.4%) |
Sep 2014 | - | $16.86M(+17.4%) |
Jun 2014 | - | $14.36M(+12.9%) |
Mar 2014 | - | $12.72M(+3.8%) |
Dec 2013 | $52.60M(+1.8%) | $12.26M(-3.7%) |
Sep 2013 | - | $12.73M(-8.4%) |
Jun 2013 | - | $13.90M(+1.4%) |
Mar 2013 | - | $13.71M(+2.5%) |
Dec 2012 | $51.69M(+18.9%) | $13.37M(+0.3%) |
Sep 2012 | - | $13.32M(+11.5%) |
Jun 2012 | - | $11.95M(-8.5%) |
Mar 2012 | - | $13.06M(+22.5%) |
Dec 2011 | $43.49M(-7.9%) | $10.66M(-4.7%) |
Sep 2011 | - | $11.19M(+1.2%) |
Jun 2011 | - | $11.06M(+4.6%) |
Mar 2011 | - | $10.57M(-23.3%) |
Dec 2010 | $47.22M | $13.79M(+15.1%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2010 | - | $11.98M(+13.8%) |
Jun 2010 | - | $10.53M(-3.6%) |
Mar 2010 | - | $10.92M(-16.1%) |
Dec 2009 | $54.07M(-39.4%) | $13.02M(+25.6%) |
Sep 2009 | - | $10.37M(-33.7%) |
Jun 2009 | - | $15.63M(+3.9%) |
Mar 2009 | - | $15.04M(-48.8%) |
Dec 2008 | $89.22M(-58.2%) | $29.39M(+78.5%) |
Sep 2008 | - | $16.46M(-21.0%) |
Jun 2008 | - | $20.85M(-7.4%) |
Mar 2008 | - | $22.51M(-82.6%) |
Dec 2007 | $213.47M(+39.9%) | $129.13M(+339.7%) |
Sep 2007 | - | $29.37M(+6.4%) |
Jun 2007 | - | $27.60M(+0.8%) |
Mar 2007 | - | $27.38M(+6.5%) |
Dec 2006 | $152.55M(+2.4%) | $25.70M(-37.7%) |
Sep 2006 | - | $41.27M(+7.2%) |
Jun 2006 | - | $38.51M(-18.2%) |
Mar 2006 | - | $47.07M(+21.6%) |
Dec 2005 | $148.96M(+8.3%) | $38.70M(-2.3%) |
Sep 2005 | - | $39.62M(+0.5%) |
Jun 2005 | - | $39.42M(+26.3%) |
Mar 2005 | - | $31.21M(-21.3%) |
Dec 2004 | $137.51M(-30.5%) | $39.67M(+5.1%) |
Sep 2004 | - | $37.73M(+32.7%) |
Jun 2004 | - | $28.44M(-10.2%) |
Mar 2004 | - | $31.67M(-28.8%) |
Dec 2003 | $197.87M(+62.6%) | $44.51M(+3.9%) |
Sep 2003 | - | $42.83M(-25.5%) |
Jun 2003 | - | $57.46M(+8.3%) |
Mar 2003 | - | $53.07M(+17.5%) |
Dec 2002 | $121.66M(+42.9%) | $45.15M(+64.3%) |
Sep 2002 | - | $27.48M(+4.7%) |
Jun 2002 | - | $26.25M(+15.2%) |
Mar 2002 | - | $22.78M(-19.3%) |
Dec 2001 | $85.12M(+69.6%) | $28.24M(+38.4%) |
Sep 2001 | - | $20.40M(+7.8%) |
Jun 2001 | - | $18.92M(+7.7%) |
Mar 2001 | - | $17.57M(+18.3%) |
Dec 2000 | $50.19M(+36.8%) | $14.86M(-1.0%) |
Sep 2000 | - | $15.01M(+45.4%) |
Jun 2000 | - | $10.32M(+3.2%) |
Mar 2000 | - | $10.00M(+8.7%) |
Dec 1999 | $36.70M(+29.2%) | $9.20M(-9.8%) |
Sep 1999 | - | $10.20M(+12.1%) |
Jun 1999 | - | $9.10M(+12.3%) |
Mar 1999 | - | $8.10M(-1.2%) |
Dec 1998 | $28.40M(+10.9%) | $8.20M(0.0%) |
Sep 1998 | - | $8.20M(+43.9%) |
Jun 1998 | - | $5.70M(-12.3%) |
Mar 1998 | - | $6.50M(-13.3%) |
Dec 1997 | $25.60M(+57.1%) | $7.50M(+13.6%) |
Sep 1997 | - | $6.60M(+15.8%) |
Jun 1997 | - | $5.70M(0.0%) |
Mar 1997 | - | $5.70M(-5.0%) |
Dec 1996 | $16.30M | $6.00M(+62.2%) |
Sep 1996 | - | $3.70M(-11.9%) |
Jun 1996 | - | $4.20M(+75.0%) |
Mar 1996 | - | $2.40M |
FAQ
- What is Neurocrine Biosciences annual total expenses?
- What is the all time high annual total expenses for Neurocrine Biosciences?
- What is Neurocrine Biosciences annual total expenses year-on-year change?
- What is Neurocrine Biosciences quarterly total expenses?
- What is the all time high quarterly total expenses for Neurocrine Biosciences?
- What is Neurocrine Biosciences quarterly total expenses year-on-year change?
What is Neurocrine Biosciences annual total expenses?
The current annual total expenses of NBIX is $1.77B
What is the all time high annual total expenses for Neurocrine Biosciences?
Neurocrine Biosciences all-time high annual total expenses is $1.77B
What is Neurocrine Biosciences annual total expenses year-on-year change?
Over the past year, NBIX annual total expenses has changed by +$280.00M (+18.76%)
What is Neurocrine Biosciences quarterly total expenses?
The current quarterly total expenses of NBIX is $548.90M
What is the all time high quarterly total expenses for Neurocrine Biosciences?
Neurocrine Biosciences all-time high quarterly total expenses is $548.90M
What is Neurocrine Biosciences quarterly total expenses year-on-year change?
Over the past year, NBIX quarterly total expenses has changed by +$138.90M (+33.88%)